Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | EPHX1 | P07099 | 2/20 | 0.36 |
| ▸ | DPP4 | P27487 | 2/20 | 0.34 |
| ▸ | GBA1 | P04062 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | CCNE1 | P24864 | 5/20 | 0.32 |
| ▸ | CDK2 | P24941 | 5/20 | 0.32 |
| ▸ | GSK3B | P49841 | 4/20 | 0.32 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.32 |
| ▸ | CDK9 | P50750 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28348910 | 1.00 | THRB (0.42) | THRBEPHX1DPP4GBA1SMN1; SMN2 | |
| SCHEMBL28457660 | 0.95 | EPHX1 (0.38) | THRBEPHX1DPP4GBA1SMN1; SMN2 | |
| SCHEMBL27821593 | 0.90 | THRB (0.34) | THRBEPHX1DPP4GBA1SMN1; SMN2 | |
| SCHEMBL25270841 | 0.88 | EPHX1 (0.39) | THRBEPHX1DPP4SMN1; SMN2TSHR | |
| SCHEMBL27771663 | 0.83 | GBA1 (0.34) | DPP4GBA1SMN1; SMN2TSHRMAPK1 | |
| SCHEMBL28172505 | 0.83 | EPHX1 (0.35) | EPHX1DPP4SMN1; SMN2CCNE1CDK2 | |
| SCHEMBL28172529 | 0.83 | DPP4 (0.36) | EPHX1DPP4SMN1; SMN2CCNE1CDK2 | |
| SCHEMBL28348956 | 0.83 | DPP4 (0.36) | EPHX1DPP4SMN1; SMN2CCNE1CDK2 | |
| SCHEMBL25277512 | 0.80 | EPHX1 (0.36) | EPHX1DPP4SMN1; SMN2CCNE1CDK2 | |
| SCHEMBL12669754 | 0.79 | EPHX1 (0.48) | EPHX1DPP4SMN1; SMN2TSHRRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106068264-B | Pyrimidine pyrazolyl derivatives and their use as IRAK inhibitors | 默克专利有限公司 | 2019-06-21 | — | — | CN | disclosed |
| CN-107531693-A | Novel 5 or 8-substituted imidazo [1, 5-a ] pyridines as inhibitors of indoleamine 2, 3-dioxygenase and/or tryptophan 2, 3-dioxygenase | 百济神州有限公司 | 2018-01-02 | — | — | CN | disclosed |
| CN-104640855-B | Complement is by way of conditioning agent and application thereof | 诺华股份有限公司 | 2017-08-29 | — | — | CN | disclosed |
| CN-106068264-A | PYRIMIDINE PYRAZOLYL DERIVATIVES AND THEIR USE AS IRAK INHIBITORS | 默克专利有限公司 | 2016-11-02 | — | — | CN | disclosed |
| CN-104640855-A | Complement pathway modulators and uses thereof | NOVARTIS AG | 2015-05-20 | — | — | CN | disclosed |
| CN-101821245-B | New compounds | BOEHRINGER INGELHEIM INT | 2012-10-10 | — | — | CN | disclosed |
| CN-101821245-A | New compounds | BOEHRINGER INGELHEIM INT | 2010-09-01 | — | — | CN | disclosed |
| CN-101163662-A | Phenylacetylene derivatives having mglur5 receptor affinity | NOVARTIS AG (CH) | 2008-04-16 | — | — | CN | disclosed |
| CN-101160282-A | Acetylene derivative | NOVARTIS AG NOVARTIS PHARMA GM (CH) | 2008-04-09 | — | — | CN | disclosed |